Restrictive lung disease
(Redirected from Restrictive ventilatory defect)
Restrictive lung disease is a category of respiratory disease characterized by a reduction in lung volume, either due to an alteration in lung parenchyma or because of a disease of the pleura, chest wall, or neuromuscular apparatus. It is one of the two main types of lung diseases, the other being obstructive lung disease.
Causes[edit | edit source]
Restrictive lung disease can be caused by a variety of conditions, including Interstitial lung disease, Sarcoidosis, Obesity, Scoliosis, Neuromuscular diseases, and Pleural effusion. These conditions can lead to a decrease in lung volume, making it harder for the lungs to fully expand and take in air.
Symptoms[edit | edit source]
The main symptoms of restrictive lung disease are shortness of breath, cough, and fatigue. These symptoms can be caused by the reduced lung volume and the resulting decrease in oxygen exchange.
Diagnosis[edit | edit source]
The diagnosis of restrictive lung disease is typically made through a combination of medical history, physical examination, and pulmonary function tests. These tests measure the volume and speed of air as it is inhaled and exhaled from the lungs. In restrictive lung disease, the total amount of air that the lungs can hold is often reduced.
Treatment[edit | edit source]
Treatment for restrictive lung disease depends on the underlying cause. It often involves treating the underlying condition, such as weight loss for obesity-related lung disease or medication for interstitial lung disease. In some cases, pulmonary rehabilitation or lung transplantation may be recommended.
Prognosis[edit | edit source]
The prognosis for restrictive lung disease varies depending on the underlying cause. Some conditions, such as interstitial lung disease, can lead to progressive lung damage and may be life-threatening. Others, such as obesity-related lung disease, can often be improved with treatment.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD